Regulation of tumor growth as a 'total mass' in mice: Apoptosis as a major mechanism in altering growth rates of single and multiple coexisting tumor nodules

Pathology International

Volumn 48, Issue 9, 1998, Pages 730-738

  Naora, Honami ^a   Seno, Satimaru ^b   Naora, Hiroto ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b Shigei Medical Research Institute   (Japan)

Author keywords

Apoptosis; Growth regulation; ras induced fibrosarcoma; Tumor growth

Indexed keywords

DNA; RNA;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; FIBROSARCOMA; GROWTH REGULATION; HISTOLOGY; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE RAS; PRIORITY JOURNAL; SOLID TUMOR; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR VOLUME;

EID: 0031662483     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03974.x     Document Type: Article

References (32)

1. Laird AK. Dynamics of tumor growth. Br. J. Cancer 1964; 18: 490-502.
2. Laird AK. Dynamics of tumor growth: Comparison of growth rates and extrapolation of growth curve to one cell. Br. J. Cancer 1965; 19: 278-291.
3. Laird AK, Tyler SA, Barton AD. Dynamics of normal growth. Growth 1965; 29: 233-248.
4. McCredie JA, Inch WR, Kruuv J, Watson TA. The rate of tumor growth in animals. Growth 1965; 29: 331-347.
5. Goodman GJ. Effects of one tumor upon the growth of another. Proc. Am. Assoc. Cancer Res. 1957; 2: 207.
6. Prehn RT. The inhibition of tumor growth by tumor mass. Cancer Res. 1991; 51: 2-4.
7. Prehn RT. Two competing influences that may explain concomitant tumor resistance. Cancer Res. 1993; 53: 3266-3269.
8. Gorelik E. Concomitant tumor immunity and the resistance to a second tumor challenge. Adv. Cancer Res. 1983; 39: 71-120.
9. Gorelik E, Segal S, Feldman M. On the mechanism of tumor 'concomitant immunity'. Int. J. Cancer 1981; 27: 847-856.
10. Ruggiero RA, Bustuoabad OD, Bonfil RD, Meiss RP, Pasqualini CD. 'Concomitant immunity' in murine tumors of non-detectable immunogenicity. Br. J. Cancer 1985; 51: 37-48.
11. Meiss RP, Bonfil RD, Ruggiero RA, Pasqualini CD. Histologic aspects of concomitant resistance induced by non-immunogenic murine tumors. J. Natl Cancer Inst. 1986; 76: 1163-1169.
12. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int. Rev. Cytol. 1980; 68: 251-306.
13. Williams GT, Smith CA, McCarthy NJ, Grimes EA. Apoptosis: Final control point in cell biology. Trends Cell Biol. 1992; 2: 263-267.
14. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumor and normal cells. Anticancer Res. 1990; 10: 1153-1160.
15. Arenas MJ, McGregor AH, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumours bearing constitutively expressed myc, ras and HPV oncogenes. Am. J. Pathol. 1994; 144: 1045-1057.
16. Steel GG. Growth Kinetics of Tumors. Oxford University Press, Oxford, 1977.
17. Naora H, Naora H. Differential expression patterns of β-actin mRNA in cells undergoing apoptosis. Biochem. Biophys. Res. Commun. 1995; 211: 491-496.
18. Xu ZZ, Miyahara K, Liszczynsky H, Seno S, Naora H. Reversible conversion of cells between cancerous and normal states. Proc. Japan Acad. 1991; 67: 11-15.
19. Naora H, Xu ZZ, Miyahara K, Liszczynsky H, Seno S. Gene ecology: A cis-acting gene-to-gene interaction due to the spatial arrangement of genes in chromosomes affects neighbouring transfected c-H-ras expression. Chromosome Res. 1994; 2: 171-183.
20. Naora H, Nishida T, Shindo Y, Adachi M, Naora H. Association of nbl gene expression and glucocorticoid-induced apoptosis in mouse thymus in vivo. Immunology 1995; 85: 63-68.
21. Steel GG, Lamerton LF. The growth rate of human tumors. Br. J. Cancer 1966; 20: 74-86.
22. DeWys WD. Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. Cancer Res. 1972; 32: 374-379.
23. Frindel E, Malaise EP, Alpen E, Tubiana M. Kinetics of cell proliferation of an experimental tumor. Cancer Res. 1967; 27: 1122-1131.
24. Sarraf CE, Bowen ID. Kinetic studies on a murine sarcoma and an analysis of apoptosis. Br. J. Cancer 1986; 54: 989-998.
25. Steel GG. Cell loss from experimental tumors. Cell Tissue Kinet. 1968; 1: 193-207.
26. Cooper EH, Bedford AJ, Kenny TE. Cell death in normal and malignant tissues. Adv. Cancer Res. 1975; 21: 59-120.
27. Barbacid M. ras genes. Annu. Rev. Biochem. 1987; 56: 779-827.
28. Kearney R, Nelson DS. Concomitant immunity to syngeneic methylcholanthrene-induced tumors in mice: Occurrence and specificity of concomitant immunity. Aust. J. Exp. Biol. Med. Sci. 1973; 51: 723-735.
29. Ruggiero RA, Bustuoabad OD, Cramer P, Bonfil RD, Pasqualini CD. Correlation between seric antitumor activity and concomitant resistance in mice bearing non-immunogenic tumors. Cancer Res. 1990; 50: 7159-7165.
30. Franco M, Bustuoabad OD, di Gianni PD, Goldman A, Pasqualini CD, Ruggiero RA. A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumors. Br. J. Cancer 1996; 74: 178-186.
31. Gerson JM. Systemic and in situ natural killer activity in tumor-bearing mice and patients with cancer. In: Herberman R, ed. Natural Cell-Mediated Immunity Against Tumors. Academic Press, New York, 1980; 1047-1062.
32. Otu AA, Russell RJ, Wilkinson PC, White RG. Alterations of mononuclear phagocyte function induced by Lewis lung carcinoma in C57BL mice. Br. J. Cancer 1977; 36: 330-340.